this could also be funded a big pharma coming in!
A big pharma would only look to see it the product is safe and effective to determine if there is a chance of success in P3, even though the P2 vehicle numbers a skewed.
A big pharma will also ensure BoT has the right protocols in place for P3, if there was to be a funding agreement in place.
This is when big pharma strikes, when there is some bad sentiment on a product that is safe and effective goi g into P3!
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-551
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.005(1.18%) |
Mkt cap ! $761.8M | |||
| Open | High | Low | Value | Volume |
| 43.0¢ | 44.5¢ | 41.5¢ | $2.435M | 5.697M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 819538 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 29052 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |